Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.

Identifieur interne : 002537 ( PubMed/Curation ); précédent : 002536; suivant : 002538

Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.

Auteurs : Nagampalli Raghavendra Sashi Krishna [Inde] ; N S A. Krushna ; R B Narayanan ; S S Rajan ; K. Gunasekaran

Source :

RBID : pubmed:21745575

Descripteurs français

English descriptors

Abstract

Bm-33 (pepsin inhibitor homolog) produced by the human filarial parasite Brugia malayi, was expressed in Escherichia coli. Expression of rBm33 in BL21 (DE3), Rosetta-2 gami (DE3) pLysS and GJ1158 bacterial strains, results in the accumulation of a 33 kDa protein in inclusion bodies. Inactive rBm-33 was purified under the denaturing conditions and refolded by step wise dialysis using buffers of pH ranging from 11 to 7. Size exclusion chromatography of rBm-33 (refolded) reveals that nearly 83% of the recombinant protein exhibits pepsin inhibition activity. Circular dichroism studies indicate that the protein is predominantly composed of 85% α-helix. rBm-33 (refolded) was assessed for its pepsin inhibition activity using casein agar plate method, UV-spectroscopy and zymogram analysis. These findings suggest that rBm-33 (refolded) has affinity for human pepsin and completely inhibits the proteolytic activity with the gradual increase in rBm-33 (refolded) concentration. Size exclusion chromatography reveals the formation of rBm-33-pepsin complex and was cross checked using immunoblot with glutaraldehyde cross linking. These findings reveal that rBm-33 (refolded) is in native fold to exhibit pepsin inhibition.

DOI: 10.1016/j.pep.2011.06.014
PubMed: 21745575

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:21745575

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.</title>
<author>
<name sortKey="Krishna, Nagampalli Raghavendra Sashi" sort="Krishna, Nagampalli Raghavendra Sashi" uniqKey="Krishna N" first="Nagampalli Raghavendra Sashi" last="Krishna">Nagampalli Raghavendra Sashi Krishna</name>
<affiliation wicri:level="1">
<nlm:affiliation>CAS in Crystallography and Biophysics, University of Madras, Chennai 600 025, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>CAS in Crystallography and Biophysics, University of Madras, Chennai 600 025</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Krushna, N S A" sort="Krushna, N S A" uniqKey="Krushna N" first="N S A" last="Krushna">N S A. Krushna</name>
</author>
<author>
<name sortKey="Narayanan, R B" sort="Narayanan, R B" uniqKey="Narayanan R" first="R B" last="Narayanan">R B Narayanan</name>
</author>
<author>
<name sortKey="Rajan, S S" sort="Rajan, S S" uniqKey="Rajan S" first="S S" last="Rajan">S S Rajan</name>
</author>
<author>
<name sortKey="Gunasekaran, K" sort="Gunasekaran, K" uniqKey="Gunasekaran K" first="K" last="Gunasekaran">K. Gunasekaran</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21745575</idno>
<idno type="pmid">21745575</idno>
<idno type="doi">10.1016/j.pep.2011.06.014</idno>
<idno type="wicri:Area/PubMed/Corpus">002537</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002537</idno>
<idno type="wicri:Area/PubMed/Curation">002537</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002537</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.</title>
<author>
<name sortKey="Krishna, Nagampalli Raghavendra Sashi" sort="Krishna, Nagampalli Raghavendra Sashi" uniqKey="Krishna N" first="Nagampalli Raghavendra Sashi" last="Krishna">Nagampalli Raghavendra Sashi Krishna</name>
<affiliation wicri:level="1">
<nlm:affiliation>CAS in Crystallography and Biophysics, University of Madras, Chennai 600 025, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>CAS in Crystallography and Biophysics, University of Madras, Chennai 600 025</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Krushna, N S A" sort="Krushna, N S A" uniqKey="Krushna N" first="N S A" last="Krushna">N S A. Krushna</name>
</author>
<author>
<name sortKey="Narayanan, R B" sort="Narayanan, R B" uniqKey="Narayanan R" first="R B" last="Narayanan">R B Narayanan</name>
</author>
<author>
<name sortKey="Rajan, S S" sort="Rajan, S S" uniqKey="Rajan S" first="S S" last="Rajan">S S Rajan</name>
</author>
<author>
<name sortKey="Gunasekaran, K" sort="Gunasekaran, K" uniqKey="Gunasekaran K" first="K" last="Gunasekaran">K. Gunasekaran</name>
</author>
</analytic>
<series>
<title level="j">Protein expression and purification</title>
<idno type="eISSN">1096-0279</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Blotting, Western</term>
<term>Brugia malayi (enzymology)</term>
<term>Brugia malayi (genetics)</term>
<term>Caseins (metabolism)</term>
<term>Chromatography, Gel</term>
<term>Circular Dichroism</term>
<term>Cloning, Molecular (methods)</term>
<term>Elephantiasis, Filarial (metabolism)</term>
<term>Elephantiasis, Filarial (parasitology)</term>
<term>Escherichia coli</term>
<term>Glutaral (chemistry)</term>
<term>Humans</term>
<term>Inclusion Bodies (chemistry)</term>
<term>Inclusion Bodies (metabolism)</term>
<term>Kinetics</term>
<term>Pepsin A (antagonists & inhibitors)</term>
<term>Pepsin A (metabolism)</term>
<term>Plasmids</term>
<term>Protease Inhibitors (isolation & purification)</term>
<term>Protease Inhibitors (metabolism)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Protein Refolding</term>
<term>Protein Structure, Secondary</term>
<term>Recombinant Proteins (isolation & purification)</term>
<term>Recombinant Proteins (metabolism)</term>
<term>Recombinant Proteins (pharmacology)</term>
<term>Transformation, Bacterial</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Brugia malayi (enzymologie)</term>
<term>Brugia malayi (génétique)</term>
<term>Caséines (métabolisme)</term>
<term>Chromatographie sur gel</term>
<term>Cinétique</term>
<term>Clonage moléculaire ()</term>
<term>Corps d'inclusion ()</term>
<term>Corps d'inclusion (métabolisme)</term>
<term>Dichroïsme circulaire</term>
<term>Escherichia coli</term>
<term>Filariose lymphatique (métabolisme)</term>
<term>Filariose lymphatique (parasitologie)</term>
<term>Glutaraldéhyde ()</term>
<term>Humains</term>
<term>Inhibiteurs de protéases (isolement et purification)</term>
<term>Inhibiteurs de protéases (métabolisme)</term>
<term>Inhibiteurs de protéases (pharmacologie)</term>
<term>Pepsine A (antagonistes et inhibiteurs)</term>
<term>Pepsine A (métabolisme)</term>
<term>Plasmides</term>
<term>Protéines recombinantes (isolement et purification)</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Protéines recombinantes (pharmacologie)</term>
<term>Repliement des protéines</term>
<term>Structure secondaire des protéines</term>
<term>Technique de Western</term>
<term>Transformation bactérienne</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Pepsin A</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Glutaral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>Protease Inhibitors</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Caseins</term>
<term>Pepsin A</term>
<term>Protease Inhibitors</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Pepsine A</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Inclusion Bodies</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr">
<term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en">
<term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Brugia malayi</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Inhibiteurs de protéases</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Inclusion Bodies</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Cloning, Molecular</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Caséines</term>
<term>Corps d'inclusion</term>
<term>Filariose lymphatique</term>
<term>Inhibiteurs de protéases</term>
<term>Pepsine A</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de protéases</term>
<term>Protéines recombinantes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Protease Inhibitors</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Blotting, Western</term>
<term>Chromatography, Gel</term>
<term>Circular Dichroism</term>
<term>Escherichia coli</term>
<term>Humans</term>
<term>Kinetics</term>
<term>Plasmids</term>
<term>Protein Refolding</term>
<term>Protein Structure, Secondary</term>
<term>Transformation, Bacterial</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Chromatographie sur gel</term>
<term>Cinétique</term>
<term>Clonage moléculaire</term>
<term>Corps d'inclusion</term>
<term>Dichroïsme circulaire</term>
<term>Escherichia coli</term>
<term>Glutaraldéhyde</term>
<term>Humains</term>
<term>Plasmides</term>
<term>Repliement des protéines</term>
<term>Structure secondaire des protéines</term>
<term>Technique de Western</term>
<term>Transformation bactérienne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Bm-33 (pepsin inhibitor homolog) produced by the human filarial parasite Brugia malayi, was expressed in Escherichia coli. Expression of rBm33 in BL21 (DE3), Rosetta-2 gami (DE3) pLysS and GJ1158 bacterial strains, results in the accumulation of a 33 kDa protein in inclusion bodies. Inactive rBm-33 was purified under the denaturing conditions and refolded by step wise dialysis using buffers of pH ranging from 11 to 7. Size exclusion chromatography of rBm-33 (refolded) reveals that nearly 83% of the recombinant protein exhibits pepsin inhibition activity. Circular dichroism studies indicate that the protein is predominantly composed of 85% α-helix. rBm-33 (refolded) was assessed for its pepsin inhibition activity using casein agar plate method, UV-spectroscopy and zymogram analysis. These findings suggest that rBm-33 (refolded) has affinity for human pepsin and completely inhibits the proteolytic activity with the gradual increase in rBm-33 (refolded) concentration. Size exclusion chromatography reveals the formation of rBm-33-pepsin complex and was cross checked using immunoblot with glutaraldehyde cross linking. These findings reveal that rBm-33 (refolded) is in native fold to exhibit pepsin inhibition.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21745575</PMID>
<DateCreated>
<Year>2011</Year>
<Month>08</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>12</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1096-0279</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>79</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2011</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Protein expression and purification</Title>
<ISOAbbreviation>Protein Expr. Purif.</ISOAbbreviation>
</Journal>
<ArticleTitle>Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.</ArticleTitle>
<Pagination>
<MedlinePgn>245-50</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pep.2011.06.014</ELocationID>
<Abstract>
<AbstractText>Bm-33 (pepsin inhibitor homolog) produced by the human filarial parasite Brugia malayi, was expressed in Escherichia coli. Expression of rBm33 in BL21 (DE3), Rosetta-2 gami (DE3) pLysS and GJ1158 bacterial strains, results in the accumulation of a 33 kDa protein in inclusion bodies. Inactive rBm-33 was purified under the denaturing conditions and refolded by step wise dialysis using buffers of pH ranging from 11 to 7. Size exclusion chromatography of rBm-33 (refolded) reveals that nearly 83% of the recombinant protein exhibits pepsin inhibition activity. Circular dichroism studies indicate that the protein is predominantly composed of 85% α-helix. rBm-33 (refolded) was assessed for its pepsin inhibition activity using casein agar plate method, UV-spectroscopy and zymogram analysis. These findings suggest that rBm-33 (refolded) has affinity for human pepsin and completely inhibits the proteolytic activity with the gradual increase in rBm-33 (refolded) concentration. Size exclusion chromatography reveals the formation of rBm-33-pepsin complex and was cross checked using immunoblot with glutaraldehyde cross linking. These findings reveal that rBm-33 (refolded) is in native fold to exhibit pepsin inhibition.</AbstractText>
<CopyrightInformation>Copyright © 2011 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krishna</LastName>
<ForeName>Nagampalli Raghavendra Sashi</ForeName>
<Initials>NR</Initials>
<AffiliationInfo>
<Affiliation>CAS in Crystallography and Biophysics, University of Madras, Chennai 600 025, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Krushna</LastName>
<ForeName>N S A</ForeName>
<Initials>NS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Narayanan</LastName>
<ForeName>R B</ForeName>
<Initials>RB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rajan</LastName>
<ForeName>S S</ForeName>
<Initials>SS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gunasekaran</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Protein Expr Purif</MedlineTA>
<NlmUniqueID>9101496</NlmUniqueID>
<ISSNLinking>1046-5928</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002364">Caseins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.23.1</RegistryNumber>
<NameOfSubstance UI="D010434">Pepsin A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>T3C89M417N</RegistryNumber>
<NameOfSubstance UI="D005976">Glutaral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017178" MajorTopicYN="N">Brugia malayi</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002364" MajorTopicYN="N">Caseins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002850" MajorTopicYN="N">Chromatography, Gel</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005976" MajorTopicYN="N">Glutaral</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010434" MajorTopicYN="N">Pepsin A</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058849" MajorTopicYN="N">Protein Refolding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014169" MajorTopicYN="N">Transformation, Bacterial</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>03</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2011</Year>
<Month>06</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>06</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>7</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21745575</ArticleId>
<ArticleId IdType="pii">S1046-5928(11)00161-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.pep.2011.06.014</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002537 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002537 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:21745575
   |texte=   Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:21745575" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024